Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 98

1.

HIV-2 Infection Surveillance--United States, 1987-2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):985-8.

2.

Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.

Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, Leidner J, van Widenfelt E, Moffat C, Moyo S, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2011 Aug 15;204(4):506-14. doi: 10.1093/infdis/jir307.

3.

HIV surveillance--United States, 1981-2008.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jun 3;60(21):689-93. Erratum in: MMWR Morb Mortal Wkly Rep. 2011 Jul 1;60(25):852.

4.

Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.

Tariq S, Townsend CL, Cortina-Borja M, Duong T, Elford J, Thorne C, Tookey PA; European Collaborative Study.; National Study of HIV in Pregnancy Childhood..

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):326-33. doi: 10.1097/QAI.0b013e31821d34d0. Erratum in: J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):e117.

5.

The future of HIV testing.

Branson BM.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S102-5. doi: 10.1097/QAI.0b013e3181fbca44.

PMID:
21406978
6.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group., de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
7.

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD.

J Am Coll Cardiol. 2011 Jan 4;57(1):76-85. doi: 10.1016/j.jacc.2010.08.620.

8.

Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.

Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, Mofenson L, Stanley K, Newell ML, Mandelbrot L, Delfraissy JF, Cunningham CK.

J Perinat Med. 2011 Mar;39(2):163-70. doi: 10.1515/JPM.2010.139. Epub 2010 Dec 13.

9.

Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways.

Kourtis AP, Bulterys M.

Clin Perinatol. 2010 Dec;37(4):721-37, vii. doi: 10.1016/j.clp.2010.08.004.

PMID:
21078446
10.

Perinatal HIV and its prevention: progress toward an HIV-free generation.

Fowler MG, Gable AR, Lampe MA, Etima M, Owor M.

Clin Perinatol. 2010 Dec;37(4):699-719, vii. doi: 10.1016/j.clp.2010.09.002. Review.

PMID:
21078445
11.

Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.

Rudin C, Spaenhauer A, Keiser O, Rickenbach M, Kind C, Aebi-Popp K, Brinkhof MW; Swiss HIV Cohort Study (SHCS).; Swiss Mother & Child HIV Cohort Study (MoCHiV)..

HIV Med. 2011 Apr;12(4):228-35. doi: 10.1111/j.1468-1293.2010.00876.x. Epub 2010 Aug 18.

12.

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.

Pinnetti C, Baroncelli S, Villani P, Fantoni M, Tozzi V, De Luca A, Cauda R, Anzidei G, Cusato M, Regazzi M, Floridia M, Tamburrini E.

J Antimicrob Chemother. 2010 Sep;65(9):2050-2. doi: 10.1093/jac/dkq264. Epub 2010 Jul 14. No abstract available.

PMID:
20630894
13.

Antiretroviral drugs to prevent breastfeeding HIV transmission.

Mofenson LM.

Antivir Ther. 2010;15(4):537-53. doi: 10.3851/IMP1574. Review.

PMID:
20587847
14.

Antiretroviral regimens in pregnancy and breast-feeding in Botswana.

Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, Makhema J, Moyo S, Thior I, McIntosh K, van Widenfelt E, Leidner J, Powis K, Asmelash A, Tumbare E, Zwerski S, Sharma U, Handelsman E, Mburu K, Jayeoba O, Moko E, Souda S, Lubega E, Akhtar M, Wester C, Tuomola R, Snowden W, Martinez-Tristani M, Mazhani L, Essex M.

N Engl J Med. 2010 Jun 17;362(24):2282-94. doi: 10.1056/NEJMoa0907736.

15.

Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.

Kesho Bora Study Group..

J Acquir Immune Defic Syndr. 2010 Aug;54(5):533-41. doi: 10.1097/QAI.0b013e3181e36634.

PMID:
20543706
16.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team..

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112. Epub 2010 Jan 18.

17.

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Aldrovandi GM, Chu C, Shearer WT, Li D, Walter J, Thompson B, McIntosh K, Foca M, Meyer WA 3rd, Ha BF, Rich KC, Moye J Jr.

Pediatrics. 2009 Dec;124(6):e1189-97. doi: 10.1542/peds.2008-2771. Epub 2009 Nov 23.

18.

Lack of effect on prematurity, birth weight, and infant growth from exposure to protease inhibitors in utero and after birth.

Carceller A, Ferreira E, Alloul S, Lapointe N.

Pharmacotherapy. 2009 Nov;29(11):1289-96. doi: 10.1592/phco.29.11.1289.

PMID:
19857146
19.

Rapid versus standard testing for prenatal HIV screening in a predominantly Hispanic population.

Tung CS, Sangi-Haghpeykar H, Levison J.

J Perinatol. 2010 Jan;30(1):30-2. doi: 10.1038/jp.2009.122. Epub 2009 Sep 10.

PMID:
19741654
20.

Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.

Garcia-Tejedor A, Maiques V, Perales A, Lopez-Aldeguer J.

Acta Obstet Gynecol Scand. 2009;88(8):882-7. doi: 10.1080/00016340903062836.

PMID:
19557554

Supplemental Content

Support Center